Unspecified monoclonal antibody
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Unspecified monoclonal antibody, covering 2013-05-15 to 2025-08-14. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of Monoclonal Antibody (mAb) in Patients With IPF (SAD). [Phase 1]